CME Group Inc. (NASDAQ:CME) Director Ronald A. Pankau sold 300 shares of the firm’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $124.78, for a total transaction of $37,434.00. Following the sale, the director now owns 4,009 shares in the company, valued at $500,243.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of CME Group Inc. (NASDAQ:CME) traded up 0.67% during mid-day trading on Friday, hitting $125.83. 1,222,844 shares of the company traded hands. The firm has a 50-day moving average of $123.71 and a 200-day moving average of $120.57. The stock has a market capitalization of $42.60 billion, a price-to-earnings ratio of 25.68 and a beta of 0.73. CME Group Inc. has a one year low of $98.95 and a one year high of $127.96.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The company had revenue of $925 million during the quarter, compared to analyst estimates of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.14 earnings per share. On average, equities analysts predict that CME Group Inc. will post $4.82 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 annualized dividend and a yield of 2.10%. CME Group’s payout ratio is currently 53.99%.

COPYRIGHT VIOLATION WARNING: “Ronald A. Pankau Sells 300 Shares of CME Group Inc. (NASDAQ:CME) Stock” was first published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/05/ronald-a-pankau-sells-300-shares-of-cme-group-inc-nasdaqcme-stock.html.

A number of research firms recently weighed in on CME. Deutsche Bank AG raised their target price on shares of CME Group from $136.00 to $137.00 and gave the company a “buy” rating in a research report on Tuesday, April 18th. Citigroup Inc. began coverage on shares of CME Group in a research report on Wednesday, July 12th. They issued a “buy” rating and a $140.00 price objective for the company. Royal Bank Of Canada set a $130.00 price objective on shares of CME Group and gave the company a “buy” rating in a research report on Monday, June 12th. UBS AG reissued a “buy” rating and issued a $134.00 price objective (down previously from $136.00) on shares of CME Group in a research report on Monday, June 5th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $128.00 price objective on shares of CME Group in a research report on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $131.63.

A number of institutional investors have recently bought and sold shares of CME. Guardian Life Insurance Co. of America raised its position in CME Group by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock valued at $156,000 after buying an additional 9 shares during the last quarter. Honkamp Krueger Financial Services Inc. raised its position in CME Group by 0.4% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after buying an additional 13 shares during the last quarter. Pitcairn Co. raised its position in CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock valued at $386,000 after buying an additional 14 shares during the last quarter. Buffington Mohr McNeal raised its position in CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock valued at $570,000 after buying an additional 15 shares during the last quarter. Finally, Summit Asset Management LLC raised its position in CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock valued at $358,000 after buying an additional 16 shares during the last quarter. Institutional investors own 83.17% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.